Skip to main content

Posts

Showing posts with the label hepatitis B virus

Study on Human Vaccines for Oncogenic Viruses and Perspectives for Tumor Antigens Induced by Virus | Chapter 7 | Innovations in Medicine and Medical Research Vol.2

The Variola major, the virus that causes the smallpox, lethal virus in the 30% of the cases, was eraticated in 1979 in the human species, thanks to a capillary vaccination on global scale. Recently the Word Health Organization (WHO) declared that India and Southeast Asia are polio-free, really a great achivement since the vaccine for polio, an infectious desease that can cause paralysis, was certificated safe and useful only 60 years ago. The vaccine for the virus, responsible for hepatitis B infection HBV, is able to prevent 50% of all liver cancers. Human Papilloma Virus (HPV) have been correlated with the cervical cancer (genotypes 16 and 18 particularly oncogenic in humans): the USA Food and Drug Administration (FDA) in 2006 released the first vaccine against HPV. Finally, the ability of the immune system to recognize a tumor-associated antigen enables the development of a vaccine approach for therapeutic application and represents a main target of this field of research. Long yea...

Relation of the Prevalence of Hepatitis B and C Viruses with Tumor Necrosis Factor- α among Patients in Babylon Province | Chapter 7| Theory and Applications of Microbiology and Biotechnology Vol. 3

Background: Hepatitis is a liver disease caused by infectious and non-infectious agents. Hepatitis B and C are global health problem. Hepatitis B (HBV) and C virus (HCV) infections are usually occur in the population due to their divers mode of transmission through blood. Objectives: This study aimed to assess the prevalence of hepatitis B and C virus among population in Babylon province and evaluation of the levels of the TNF-alpha in infected patients with hepatitis B and C. Methods: The study was conducted on individuals referred to the Central Public Health Laboratory to detected the prevalence of HBV and HCV infections in Babylon province. A total of 6061 samples was involved in this study, they surveyed by VIDAS test for demonstration of both viruses, then confirmed by real- time PCR. Concentration of TNF- α was measured in patients with hepatitis B and C and control group (Control group included healthy individuals with no history of renal or liver diseases and negative result...